SS
Sandeep Singh
About Sandeep Singh
Data last updated:
Sandeep Singh is a Director at Isis Pharmaceuticals Private Limited (since 2003). The company operates in Trading. Isis Pharmaceuticals Private Limited reported revenue of ₹6,600 (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Isis Pharmaceuticals Private Limited U24231HR2002PTC034882 | Director | 14 May 2003 | 2002 | ₹6,600 (FY 2024) | Active |
Board colleagues of Sandeep Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jitender Deewan | 00474330 | Isis Pharmaceuticals Private Limited | Director |
| Lokesh Anand | 00474345 | Isis Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sandeep Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sandeep Singh
Sandeep Singh currently holds 1 directorship: Isis Pharmaceuticals Private Limited (Director, since 14 May 2003, revenue ₹6,600 (FY 2024)).
Sandeep Singh was first appointed on 14 May 2003 as Director at Isis Pharmaceuticals Private Limited.
The current boards of Sandeep Singh's companies include Jitender Deewan (Isis Pharmaceuticals Private Limited), Lokesh Anand (Isis Pharmaceuticals Private Limited).